Pediatric Exclusivity Breaks 3-Month Cap In House, But Still Must Find Offset

The legislation to renew the pediatric exclusivity language in the House now provides six months for all products as opposed to the sales-tiered incentives in the Senate bill, but the more generous offer serves to underline the challenge to the program - finding an offset to pay for it

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet